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Sub-Saharan Africa’s “Other Diseases”:  
A Comparison of the Global Response to Neglected  
Tropical Diseases and HIV/AIDS in Ghana 
Abbreviations:  
UN- United Nations 
MDG- Millennium Development Goals 
SDG- Sustainable Development Goals 
NTD- Neglected Tropical Disease 
TB- Tuberculosis 
SSA- Sub-Saharan Africa 
GoG- Government of Ghana 
GBD- Global Burden of Disease 
DALYs- Disability Adjusted Life Years 
YLL- Years of Life Lost 
YLD- Years Lost due to Disability 
GHS- Ghana Health Service 
PPP- Public-Private Partnership 
STH- Soil Transmitted Helminths 
LF- Lymphatic Filariasis  
WHO- World Health Organization 
SAC- School age children 
HAT- Human African Trypanosaniasis 
MDA- Mass drug administration 
ART- Antiretrovirals 
GAC- Ghana AIDS Commission 
Introduction: 
 The Millennium Development Goals (MDGs) were established by the United Nations in 
September 2000 as targets for international progress. These eight goals, which include 
eradicating extreme poverty, achieving universal education, and promoting gender equality, were 
unanimously supported by the UN’s member states. Though progress varied based on countries 
and targets, since the MDGs’ inception the number of people living in extreme poverty has more 
than halved and international support from developed nations to less developed countries has 
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increased 66% (“The Millennium Development Goals Report 2015”). The United Nations 
Development Programme claims that these achievements, as well as others, distinguish the 
MDGs as producing “the most successful anti-poverty movement in history”. The Millennium 
Development Goals were superseded by seventeen Sustainable Development Goals (SDGs), 
proposed in September 2015. 
 Despite the goal of addressing multiple indicators of poverty, the MDGs overlooked a 
crucial aspect of the relationship between healthcare and poverty. Though three of the eight goals 
are devoted to healthcare development, Goal Six, to “Combat HIV/AIDS, malaria, and other 
diseases” disregards the latter in terms of over a dozen chronic diseases that disproportionately 
affect the poor. These “other diseases” likely include what are known as the neglected tropical 
diseases, and, according to the World Health Organization, affect more than 1.4 billion people 
worldwide (“Neglected Tropical Diseases”). Many of these diseases have disabling and 
disfiguring effects that impact communities and keep those inflicted from escaping poverty. 
Even in the SDGs, Goal 3, to “Ensure healthy lives and promote well-being for all at all ages”, 
references NTDs just once when noting that the UN hopes to eliminate HIV/AIDS, tuberculosis, 
malaria, and NTDs by 2030. 
 The United Nations is not the only entity that prioritizes HIV/AIDS and malaria, as well 
as tuberculosis (collectively nicknamed “The Big Three”), over NTDs; after all, the diseases are 
called “neglected” for a reason. Living in the shadow of HIV/AIDS and the rest of The Big 
Three has kept global awareness of NTDs low and thus NTD programs worldwide receive 
considerably less funding from non-governmental organizations, charities, and other initiatives. 
This is especially detrimental for two reasons: Firstly, the cost of treating and preventing the 
most prevalent NTDs costs less than a dollar per person per year (which is extremely low 
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especially when compared to the high cost of antiretroviral treatment for HIV patients). 
Secondly, because of the morbidity of certain diseases, NTDs cause arguably greater harm to the 
well-being of low to middle-income nations than HIV/AIDS. Thus, if a country dedicates more 
national and international resources to the prevention and treatment of neglected tropical 
diseases, that nation will see an increase in social and economic development. Using Ghana as an 
example, this research will examine the nation’s funding and support for NTDs compared to that 
for HIV/AIDS and the effects on development that would occur if the former cause received the 
same global support as the latter. This paper will first review literature regarding NTDs and 
development, followed by the current situation in Ghana and what is being done to address 
endemic diseases. Additionally, the relationship between HIV/AIDS and development will be 
assessed, first through an examination of the literature and then through Ghana’s approach to 
HIV/AIDS. This paper will conclude with an analysis of the disparities between support for 
NTDs and HIV/AIDS and opportunities for further research.   
Literature Review- Neglected Tropical Diseases: 
 The term ‘neglected tropical diseases’ first appeared in 2005 and refers to “group of 
chronic, disabling, and disfiguring conditions that occur most commonly in the setting of 
extreme poverty, especially among the rural poor and some disadvantaged urban populations” 
(Hotez and Kamath). Most of these seventeen diseases, which include Chagas disease, 
schistosomiasis, and hookworm, occur in low resource settings in sub-Saharan Africa. 
Populations in Latin America and Southeast Asia are also affected to a lesser degree. While 
neglected tropical diseases can be found throughout these regions, they are most common in 
areas of abject poverty due to poor sanitation and little public health infrastructure. Research 
shows that 100% of low income countries are affected by at least five NTDs (Manderson et. al). 
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The neglected tropical diseases’ relationship with poverty is a vicious cycle; NTDs often occur in 
marginalized areas and their disabling effects perpetuate poverty.  
 NTDs generally have low mortality rates, but varying rates of morbidity; symptoms and 
physical deformities caused by NTDs often leave those affected unable to work or participate in 
day-to-day activities. This loss of ‘healthy’ life is also known as the burden of disease. The 
World Health Organization (WHO) measures the global burden of diseases (GBD) in Disability-
Adjusted Life Years (DALYs), which are “calculated as the sum of the Years of Life Lost (YLL) 
due to premature mortality in the population and the Years Lost due to Disability (YLD) for 
people living with the health condition or its consequences” (“Metrics: Disability-Adjusted Life 
Years”). This measurement was created in the 1990’s to better document the lasting effects that 
chronic diseases with low mortality rates have. Ideally, the DALY unit can help policy makers 
prioritize which diseases to focus on in terms of economic and community impact, rather than 
focusing solely on mortality. Dr. Peter J. Hotez, US Science Envoy and Dean of the Baylor 
College of Medicine National School of Tropical Medicine, states that when looked in terms of 
DALYs, NTDs “…rank closely with diarrheal diseases, ischemic heart disease, cerebrovascular 
diseases, malaria, and tuberculosis as being among the most important health problems in the 
developing world” (Hotez et. al). When looking only at mortality rates and YLL, NTDs do not 
offer the same striking effects. 
 Though the GBD DALY measurement offers a better understanding of the effects of 
NTDs, many scholars believe the measurement is flawed and that GBD calculations severely 
underestimate the burden that NTDs diseases cause. Drs. Charles H. King and Anne-Marie 
Bertino argue that the YLD is not accurate, as there is no typical or average disability of a 
disease as well as additional inhibiting factors such as poverty and access to healthcare (King 
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and Bertino).  Additionally, 
because NTDs affect mainly 
the poor living in rural areas, 
accurate epidemiological 
data is difficult to procure. 
They also argue that DALYs 
heavily stress YLL, which 
continues to emphasize 
communicable and lethal 
diseases that are more 
common in wealthier 
countries. This puts NTDs at a disadvantage, as the number of deaths due to those diseases is 
estimated to be below half a million (Hotez), a fraction of the number of deaths caused by The 
Big Three. However, even when looked at in the current DALY measurement, research from the 
WHO shows that NTDs cause 56.6 million disability-adjusted life years lost, compared to 46.5 
million DALYs due to malaria and 34.7 million DALYs lost due to TB (Utzinger et. al).  Those 
with NTDs often suffer from more than one infliction, which can cause additional impairment 
and that co-morbidity is not calculated into the DALY. 
 Figure 1 shows the disparities between YLL and YLD for each of the NTDs. For most of 
the diseases, YLD accounts for most, if not all, of the DALY calculation (Hotez, Alvarado, et. 
al). Hotez, as well as others, argue that DALY measurements do not take into effect that some 
noncommunicable diseases, such as cancer, cardiovascular disease and liver disease, may result 
 Fig. 1- Fractions of YLD and YLL (as components of DALYs) for 
 each of the NTDs (Hotez, Alvarado, et al). 
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from untreated NTDs. If GBD estimates included the link between NTDs and chronic conditions, 
there would likely be a rise in both years of life lost and years lost to disability due to NTDs. 
 The damaging effects that NTDs cause vary by disease and level of morbidity. Some 
NTDs may lead to anemia and malnourishment, while others can lead to blindness or the 
disfigurement of limbs. Symptoms may be acute and last for a few days at a time or leave the 
inflicted person permanently disabled. Studies have shown that infections are associated with 
“decreased physical function, decreased productivity, and decreased wage-earning capacity in 
later adulthood”, which King and Bertino list as a main reason why neglecting to control NTDs 
is perpetuating poverty. They also stress the lasting effects of the NTDs; most are chronic 
conditions and complications from infections often persist for half the individual’s life, even 
decades after treatment. Since those living in poverty often spend a majority of their life 
working, the physical and financial tolls NTDs take can begin early and can last a lifetime. The 
authors argue that without a better approach to NTDs, achieving the MDGs will be impossible.  
 Jeremiah Norris, Carol Adelman, Yulya Spantchak, and Kacie Marano, researchers at the 
Hudson Institute, note that the results of NTDs influence not only MDG six, but two (access to 
education), three (gender equality), four (improving child health), and five (improving maternal 
health). Many of the neglected tropical diseases disproportionately affect women and children, 
and may keep the latter from attending school on a regular basis. By controlling NTDs, multiple 
factors of poverty are addressed, and a foundation can be laid for alleviating the strain of poor 
health in impoverished areas. The authors cite the World Bank’s praise of the WHO’s 
Onchocerciasis Control Program, who called it one of “the most successful and cost-effective 
public health efforts ever launched” (6).  
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 The researchers at the Hudson Institute attribute the Onchocerciasis Control Program’s 
success partially to its use of public-private partnerships (PPPs). When national governments 
cooperating with pharmaceutical companies, international agencies (such as the World Bank and 
WHO), and non-governmental organizations, NTD interventions are more likely to succeed. 
PPPs dedicated to NTDs in Africa often cooperate with each other as well as governments and 
NGOs. Hotez, along with Drs. David H. Molyneux and Alan Fenwick write that some of the best 
approaches have been through PPPs and community-directed treatment initiatives. By 
coordinating efforts with governments and community health providers, PPPs are better able to 
distribute medications and control the transmission of NTDs. Scholars Bush and Hopkins also 
discuss the benefits of PPPs, highlighting that NGOs are more likely to succeed in increasing 
prevention and control when both international and local partnerships are created.  
 Awareness of the NTDs and their effects on impoverished populations has grown in past 
years, but remains overshadowed by the publicity on The Big Three. Critics of the institutional 
neglect regarding NTD policies and support cite the rhetoric surrounding NTDs (such as how 
they are classified as “other diseases” in the MDGs) as a vital disadvantage to the cause. By 
categorizing NTDs as “other diseases”, not only is the opportunity for name recognition lost, but 
their importance undermined. Even in MDG 6’s targets, only The Big Three are mentioned by 
name (“The Millennium Development Goals Report 2015”). Again, acknowledgment is simply 
implied in Target 8, which aims to “have halted by 2015 and begun to reverse the incidence of 
malaria and other diseases”. The Target Indicators, which are set in place to help measure MDG 
progress, list only malaria and TB in their descriptions. Hotez, Molyneux, and Fenwick state that 
the lack of awareness affects donors and policy makers’ actions; donors are hesitant to support 
causes they know little about and policy makers place a heavier focus on programs dedicated to 
Brosch 8 
 
The Big Three. King and Bertino argue that the flaws of the DALY measurement also dissuade 
politicians from taking a firmer stance on NTDs. HIV/AIDS amounts to greater DALYs lost than 
NTDs, and when looked at only in terms of YLL, HIV/AIDS’s greater mortality rate offers 
greater shock value. Since developing countries often lack adequate healthcare resources, 
delegating limited funds is a challenge. To better understand the impact that NTDs have on their 
constituents, national and international policy makers must understand the effects morbidity 
diseases have on a population, in addition to mortality rates. Global awareness of NTDs is not 
yet widespread, but is gaining traction; in 2010, the UN General Assembly recognized 
combating NTDs as an imperative step in reaching the MDGs (Norris et. al). Multiple 
governments (including high-income countries such as the United States) have expressed support 
for the prevention and control of NTDs, though they remain overshadowed by The Big Three. 
When compared to The Big Three, there is a paucity of international health organizations 
and partnerships dedicated to the control of NTDs. However, various non-governmental and 
governmental organizations have developed with the goal of eradicating NTDs or eliminating 
them as a public health problem. The WHO released a report in 2012 detailing the impact of the 
neglected tropical diseases as well as listing how NTD interventions could “contribute directly to 
the attainment of several Millennium Development Goals” (“NTD RoadMap 2012” 1). The 
WHO set goals to eradicate certain diseases in certain countries by 2020, including blinding from 
trachoma by 2010.  The report admits that the frailty of health systems in low and low-middle 
income countries may sway donors from giving aid over long periods of time. The Uniting to 
Combat Neglected Tropical Diseases coalition, supported by USAID the Bill & Melinda Gates 
foundation among many others, was founded to support the WHO in its mission of preventing 
and controlling NTDs. The coalition published the London Declaration, a commitment by the 
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coalition’s partners to mitigate the effects of NTDs by 2020, in 2012. Through donations from 
pharmaceutical companies, 3.5 billion treatments have been given to endemic countries since the 
declaration’s inception (“The Third Report: Country Leadership and Collaboration on NTDs”).  
Neglected Tropical Diseases in Ghana: 
 Ghana is endemic with twelve diseases with a high number of DALYs lost, a prohibitive 
factor in the country’s development.  A study published by the Institute for Health Metrics and 
Evaluation at the University of Washington notes that life expectancy at birth for Ghanaians is 
64.9 years, but when adjusted for health and disabilities, the figure drops to 55.3 years (“GBD 
Profile: Ghana”). The Government of Ghana (GoG) began its NTD Programme in 2006, with a 
focus on the distribution of medications known as “preventative chemotherapy” (the use of a 
combination of drugs for prevention purposes). The program, whose goal is to “prevent, control, 
eliminate or eradicate the Neglected Tropical Diseases from Ghana by the year 2020” (“Ghana 
Neglected Tropical Disease Master Plan 2013-2017”), with support from the GoG, Ghana Health 
Service, and WHO, published the Ghana Neglected Tropical Disease Master Plan in 2014. This 
five-year plan lists information about the twelve NTDs endemic in Ghana, as well as updated 
strategies on how to achieve the Programme’s goal by 2020. Many of these goals are concurrent 
with or more aggressive than global goals recommended by the WHO. The master plan lists 
yearly milestones throughout the five-year period, such reductions in prevalence or increases in 
surveillance. Operational costs were estimated at $12,676,761 USD per year for the first three 
years, with the majority of funds going to monitoring and evaluation/research and interventions 
for preventative chemotherapy diseases. In addition to funding, the GoG will distribute millions 
of donated ivermectin, praziquantel, and albendazole tablets per year. 
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Fig. 2- Neglected Tropical Diseases and their prevalence in SSA and Ghana. *These 
diseases are lethal and those infected typically die within a year of their diagnosis. 
 
Neglected Tropical Disease 
Estimated Population 
Infected in SSA 
Estimated Population 
Infected in Ghana 
Ghana 
Prevalence 
Ranking 
STH infections 29% .2-.3% - 
Schistosomiasis 25% 58% 3 
Lymphatic Filariasis 6-9% ~4% - 
Onchocerciasis 5% ~5% 7 
Trachoma 3% <.01% - 
Guinea Worm <.01% <.01% 2 
Buruli Ulcer <.01% <.01% 2 
Yaws <.01% 0.70% 1 
Rabies <.01% n/a* - 
Leprosy <.01% <.01% - 
Leishmaniasis <.01% <.01% - 
Human African 
Trypanosaniasis <.01% n/a* - 
 The Ghana Health Service (GHS), part of the GoG’s Ministry of Health, describes NTD 
prevention and control as a medium priority in terms of needed policies and additional resources. 
Despite extra funding as a result of the Master Plan, the priority ranking and lack of political 
focus on NTDs makes the goal of elimination and eradication difficult. Figure 2 lists the diseases 
currently found in Ghana, the worldwide prevalence, and the national prevalence. Ghana’s NTD 
Programme focuses mainly on treatment, however, sustainable policy efforts are needed to help 
prevent the impoverished conditions that allow these diseases to occur. Many of the NTDs are 
transmitted through contaminated drinking water or vectors such as mosquitoes or black flies. 
National policies including vector control, increased support for sanitation in poor areas, and 
better access to health care could help reduce the prevalence of most NTDs. Currently the GoG 
has no policies or framework for NTD control (“Ghana Neglected Tropical Disease Master Plan 
2013-2017” 13). Prior to the Master Plan, annual budget plans regarding NTDs were not 
consistently funded. This is partially due to financing for the health sector, as the GoG allocates 
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around only 13% of their budget for healthcare (12). This number falls short of the Abuja 
Declaration’s recommendation that all African Union countries dedicate 15% to their annual 
budget to health. As a result of limited funding, poor sanitation, and inadequate access to 
treatment, NTDs continue to be endemic in Ghana.  
 Soil transmitted helminth (STH) infections such as hookworm, ascariasis, and 
trichuriasis, are the most common NTDs in sub-Saharan Africa and account for over 30 million 
DALYs lost. These conditions account for 80% of the disease burden of the top NTDs (Norris et. 
al). It is estimated that between one-quarter and one-third of people living in SSA, as well as 
one-half of school age children (SAC), have at least one STH infection (Hotez and Kamath). The 
infections most commonly affect SAC and can cause malnutrition, stunted growth, and cognitive 
impairment. Ghana is considered endemic with a prevalence of about .2 to .3% of the population 
affected in certain districts (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 16). 
STH infections are often recurring, and endemic communities may see increases in school 
absences and poor academic performance (Hotez and Kamath). The bodily effects and lost 
education due to soil-transmitted helminthiasis can impact adulthood as well and reduce the 
victim’s earning potential later in life. Studies report that successful deworming campaigns lead 
to great economic growth in marginalized areas, and that for every $1 spent on helminth 
treatment, a community will gain more than $30 (Norris et al). The NTD Programme notes in its 
Master Plan that they hope to treat 80% of SAC for STH and reduce morbidity levels by 2020 
through MDA in schools and improved water sanitation (“Ghana Neglected Tropical Disease 
Master Plan 2013-2017” 27).  
 Schistosomiasis, also known as bilharzia or snail fever, is the second most prevalent NTD 
after hookworm, with about 192 million cases in sub-Saharan Africa (Hotez and Kamath). Ghana 
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accounts for 7.8% of these cases, tied with the Democratic Republic of the Congo as the country 
with the third highest prevalence of the disease, at an estimated 15 million citizens as of 2009. 
SAC account for the majority of cases, followed by adolescents and young adults. Most 
infections occur in those who live near irrigation schemes or large dam reservoirs (Steinmann, et. 
al). Communities in living near Ghana’s Lake Volta have a prevalence of schistosomiasis as high 
as 80-90% (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 15). Infection occurs 
through contact with freshwater that has been contaminated with snails that carry the 
schistosoma parasite, which penetrates the skin and spreads through the blood to the bladder or 
intestine. Chronic schistosomiasis may lead to scarring and inflammation of these organs, as well 
as liver, spleen, and lung damage. Symptoms of chronic infection include growth stunting, 
fatigue, diminished physical fitness, and impaired cognitive development, all which may prohibit 
those affected from working or going to school. Communities with a high prevalence of 
schistosomiasis are often poor, and the disease perpetuates poverty through missed work and 
education. Thus, the global disease burden in SSA is estimated at 1.6 to 4.2 million DALYs lost 
each year, though some research suggests that this figure may be substantially higher (Hotez and 
Kamath). The NTD Programme has called for the treatment of 80% of SAC and increased 
education, monitoring, and evaluation to eliminate morbidity as a public health problem (an 
undefined measurement) (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 27).  
 Trachoma is a disease caused by Chlamydia trachomatis. In Ghana, the disease affects 
mainly children and older women in the Northern and Upper West regions (“Ghana Neglected 
Tropical Disease Master Plan 2013-2017” 14). Spread through direct and indirect personal 
contact as well as Muscae sorbens larvae transmitted through flies, repeat infections can cause 
eyelids to turn inwards (entropion). If left untreated, eyelashes may consistently rub on the 
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eyeball (trichiasis) and result in irreversible visual impairment due to corneal scarring and 
opacification. Trachoma is considered to be the leading cause of preventable blindness of 
infectious origin worldwide (Ekuoba-Gyasi), with over 84 million people affected and 7.6 
million in the trichiasis stage (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 14). 
Trachoma is endemic in 29 of the 170 districts in Ghana, all in less developed northern regions. 
Since 2010, Ghana reported has reported no new cases reaching the trichiasis and blinding stage, 
though transmission of the disease has yet to cease (“NTD RoadMap 2012” 23). Despite the 
GoG’s reported elimination of blinding trachoma, the NTD Master Plan lists that the NTD 
Programme’s hopes to achieve the goal of elimination by 2020 (“Ghana Neglected Tropical 
Disease Master Plan 2013-2017” 27). Additionally, the Programme aims to reduce the 
prevalence of trachoma to <%.05 in children 1-9 years old and .1% in those above age 15. 
 Lymphatic Filariasis is ranked as the NTD with the third or fourth highest global disease 
burden, with an estimated 2.0 million DALYs lost each year in sub-Saharan Africa (Hotez and 
Kamath). The parasitic disease, also known as elephantiasis, is spread by mosquitoes infected 
with Wuchereria bancrofti worms, which travel through the blood stream into the lymph vessels. 
While most cases are asymptomatic (though the parasite still damages the lymph system), a 
small percentage of people will develop lymphedema or hydrocele. These conditions typically 
manifest in fluid collection and swelling of the legs, arms, breasts, and genitalia as well as the 
hardening and thickening of the skin. Aside from social and psychological stigma as a result of 
disfigurement, disabilities due to lymphedema or hydrocele can prevent workers from taking part 
in normal activities, resulting in major economic loss. This is especially detrimental to those 
living in areas of poverty, such as farmers in Northern Ghana, where episodes of acute 
adenolymphangitis (painful swelling, fever) last an average of five days (Gyapong et. al). In 
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India, estimates reported that those inflicted with chronic LF may have lost 11 years of 
productivity and 15% of their individual income per year (Norris et al). As of 2013, LF was 
present in 74 out of 170 districts in Ghana, with hydrocele or lymphedema affecting up to 4% of 
the infected population (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 15). The 
WHO hopes that by 2020, transmission will have ceded in all countries where LF is endemic 
(“NTD RoadMap 2012” 26). The NTD Programme as a more ambitious objective of eliminating 
LF by 2015 and to manage current cases through community based MDA (“Ghana Neglected 
Tropical Disease Master Plan 2013-2017” 26). 
 Onchocerciasis, known colloquially as river blindness, is another filarial infection 
transmitted through black flies. After a human is bitten by a black fly infested with the 
Onchocerca volvulus parasite, worms are released into the body’s subcutaneous tissues 
(“Onchocerciasis (river blindness) - disease information”). The larval worms spread to the skin 
and eyes, possibly resulting in severe itching and skin disfigurement, as well as irreversible 
blindness that leaves the victim disabled. As of 2009, Ghana reported the 7th highest amount of 
cases of river blindness, preceded by six other countries in SSA (“NTD RoadMap 2012” 29). 
Onchocerciasis is endemic in 40 of Ghana’s districts, with local prevalence as high as 11.1% 
(“Ghana Neglected Tropical Disease Master Plan 2013-2017” 15). To combat transmission of 
onchocerciasis, the NTD Programme hopes to increase MDA in hyper-endemic communities and 
increase vector control through the extermination of black flies. 
 Yaws, a skin disease that results in bone problems and painful ulcers covering the body, 
was thought to have been controlled or eradicated in most endemic countries by the 1970’s. 
However, following the dismantling of most yaws treatment programs, the disease has 
reemerged in impoverished communities that have little to no access to healthcare (Asiedu). 
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Ghana is the most endemic country for yaws (Kazadi et. al) with a national prevalence of about 
0.7%. Some rural communities (mainly those in the Eastern and Southern region) report 
prevalence as high as 20% in some schools (“Ghana Neglected Tropical Disease Master Plan 
2013-2017” 16). These areas, most located in the humid forest zone, tend to be overcrowded 
with insufficient clean water, leading to poor hygiene and sanitation. The GoG and the NTD 
Programme called for the the prevalence of yaws to half by 2013 and to be eliminated by 2015, 
rather than the WHO’s goal of 2020. 
 Ghana is also one of the most endemic countries for dracunculiasis, also known as 
Guinea worm disease. The disease is transmitted through drinking unfiltered water contaminated 
with copepods and is most commonly reported in SAC. About a year after consuming the water, 
a long white worm up to 1 meter in length will emerge from a blister on an appendage (most 
commonly the feet or calves) (Glenshaw et. al). The protrusion of the worm is extremely painful 
and must be done carefully to avoid breakage of the worm. If an infected person places their 
appendage in a pond or other water source to seek relief, that water may become contaminated 
and the disease can spread to others that drink it. In rural communities with inadequate access to 
healthcare, infection is often recurring. Better sanitation and clean drinking water can help 
prevent the cycle of the disease. Though Ghana has seen a major reduction in prevalence of 
Guinea worm since the creation of the Ghana Guinea Worm Eradication Programme in 1989 
(and some reports state it has been eradicated since 2011) (“Ghana Neglected Tropical Disease 
Master Plan 2013-2017” 19), it is highly likely that most cases are not being reported due to a 
lack of awareness and communication in poorer regions. The GoG offers contradictory reports 
on whether the disease has been truly eliminated, but has called for its eradication by 2015. 
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 Ghana reports the second highest number of cases of Buruli ulcer after its neighbor, Cote 
d'Ivoire. Though there are a reported 1,000 cases per year (“NTD RoadMap 2012” 33), the GoG 
states that official epidemiological data may underestimate the amount of cases due to poor 
surveillance, misdiagnoses, and a lack of diagnoses in poor communities (“Ghana Neglected 
Tropical Disease Master Plan 2013-2017” 18). The disease is caused by the Mycobacterium 
ulcerans bacterium, which can lead to chronic infection and disability (“Buruli ulcer”). In their 
2012 report, the WHO stated their hopes to treat 70% of cases through antibiotics by 2020 
(“NTD RoadMap 2012” 24). Early diagnoses and treatment can prevent permanent deformities, 
which often carry a stigma that discourages the inflicted from taking an active role in their 
community. 
 NTDs in Ghana that affect populations to a lesser extent include rabies, Human African 
Trypanosaniasis (HAT), leprosy, and leishmaniasis. These diseases, though present in the 
country, have already achieved WHO elimination targets. Surveillance for these conditions is 
done less frequently then more endemic diseases, however prior data showed no new cases of 
HAT since 2000 (“Ghana Neglected Tropical Disease Master Plan 2013-2017” 17). Rabies cases 
are rarely confirmed by healthcare providers and there is little official data on the topic. The 
latest data referenced in the Master Plan listed 8980 cases of leishmaniasis in 2004 (8) and 547 
new cases of leprosy in 2011 (19). 
 Most NTDs can be treated or cured through a single dose of certain medications. The use 
of mass drug administration (MDA) including albendazole, praziquantel, ivermectin or 
diethylcarbamazine, and azithromycin, has seen positive effects on multiple diseases in the 
developing world. MDA efforts have led to near eradication of LF in Egypt and Zanzibar and 
trachoma in Morocco (Hotez et. al). An integrated MDA approach using a combination of the 
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four medications can prevent or treat the seven most common NTDs for as little as $0.50 per 
person per year. This is especially notable when compared to malaria and HIV/AIDS treatment, 
which cost $6.64 and $700 per case annually. Studies have shown an economic return rate of 
15% to 30%, with “conservative estimates at $20 in benefits for every $1 invested” (Norris et. al) 
for LF alone. This is because NTD treatment and control prevents physical problems from 
occurring, thus concurrently preventing the stigma from disabilities and disfigurements that 
many victims face. When NTDs and their symptoms are treated, citizens are better able to attend 
school and work regularly, boosting their earning potential and benefitting their nation’s 
economy.  
Literature Review- HIV/AIDS: 
 Though neglected tropical diseases have plagued humans for centuries, human 
immunodeficiency virus (commonly abbreviated as HIV) and acquired immunodeficiency 
syndrome (AIDS) was only discovered in the past century. The condition was first described in 
the early 1980’s after doctors reported multiple cases of Pneumocystis carinii pneumonia in 
homosexual men (De Cock et. al). Researchers would soon identify the correlation between 
sexual intercourse and/or intravenous drug use and HIV/AIDS, as well as the virus’s high 
mortality rate. Though studies began in the U.S., epidemiologists discovered a much larger 
prevalence in those residing in SSA. Today, the WHO estimates that 36.9 million people are 
living with HIV/AIDS, with SSA accounting for 25.8 million cases (“HIV/AIDS”).  
 HIV is transmitted through bodily fluids and those infected may not show symptoms for 
weeks or months. The virus weakens the immune system and may lead to weight loss, flu-like 
symptoms, and increased susceptibility to other infections like tuberculosis, meningitis, and 
some cancers (“HIV/AIDS”). The advanced stage of the virus, which is defined as a T cell count 
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less than 200 or the development of certain conditions, is known as AIDS and may take 2 to 15 
years to develop. Though there is no cure for HIV or AIDS, damage to the immune system can 
be delayed through the use of antiretroviral drugs (ART). The WHO reports that an estimated 
14.9 million people (or 40% of those living with HIV/AIDS) are receiving ART treatments. 
Similar to NTDs, the highest prevalence of HIV/AIDS exists in SSA. A study published by the 
Institute of Health Metrics estimates that HIV/AIDS accounts for 3.3% of the global disease 
burden at 81 million DALYs lost (Ortblad, Lozano, and Murray). Only 5.3% of the DALYs were 
due to YLDs, with the remaining 94.7% due to YLLs. HIV/AIDS also carries a negative stigma 
among victims.  
 Due to increased awareness following the 1980s, global support for HIV/AIDS dwarfs 
that for any other health related cause. This is especially true for donations given to countries in 
SSA, where most international awareness is focused on. Dr. Peter Amico of Brandeis University 
and Christian Aran and Carlos Avila of UNAIDS argue that the funding for HIV/AIDS in SSA is 
disproportionate to the actual disease burden (especially when compared to other regions like 
Southeastern Asia). The decision on where funding goes does not reflect how many people have 
the disease or where the disease is most prevalent. Drs. Christopher J.L. Murray and Joseph 
Dieleman of the Institute for Health Metrics and Evaluation note inequalities in international 
assistance as well, such as how countries “received less than US$60 of malaria funding for every 
year of healthy life lost to malaria, [while] Latin America and the Caribbean received nearly 
US$2,000 of malaria funding per year of healthy life lost”. While external global support has 
increased over time, funding is often distributed based on donor preference rather than recipient 
need. 
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 Domestic spending on HIV/AIDS surpassed international support in 2011, and was 
estimated by the Kaiser Family Foundation to have totaled about US$9.65 billion in 2013 (Kates, 
Wexler, and Lief). In 2012, two-thirds of low and low-middle income countries (LMICs) 
increased their funding for HIV/AIDS. However, despite these increases, healthcare in LMICs 
depend on foreign aid. The United States is the largest provider of governmental assistance 
toward HIV/AIDS care, with the President’s Emergency Plan for AIDS Relief (PEPFAR) 
accounting for 73% of bilateral aid and 23% of total HIV funding in 2013. Overall, donor 
governments funded over $8.46 billion for HIV/AIDS that same year. Multilateral organizations 
such as The Global Fund to Fight AIDS, Tuberculosis, and Malaria and the World Bank, as well 
as charities such as the Bill & Melinda Gates Foundation also contribute large sums to 
HIV/AIDS care.   
 The Institute for Health Metrics and Evaluation reports that in 2011, $7.7 billion USD 
was given in health assistance for HIV/AIDS (Murray and Dieleman).  “Other diseases”, which 
likely includes NTDs and encompasses everything but malaria, TB, maternal/child health, 
noncommunicable diseases, tobacco, and health sector support, accounted for just $6.5 billion 
USD. Overall, total spending for The Big Three equaled over $10.7 billion USD, or one-third of 
global health spending. In 2012, the U.S. government donated $7.1 billion USD in health aid, of 
which only $89 million USD went to NTDs (Norris et. al 15). In contrast, at least $4.2 billion 
USD was allocated for HIV/AIDS and malaria programs. 
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 Analysis of HIV/AIDS’s impact on poverty varies among scholars and studies. Drs. Peter 
Piot, Robert Greener, and Sarah Russell counter the misconception that the condition affects 
mainly the poor by 
noting that “the fact 
that most people 
living with HIV in 
the region today are 
poor simply reflects 
the fact that the 
epidemic has now 
spread throughout 
the generalized 
population in a 
region that has a high 
proportion of poor people”. Being “poor” is a matter of perspective. Countries endemic with 
HIV/AIDS often see the highest prevalence among their wealthier citizens (though not the 
wealthiest), especially those living in urban areas. Piot, Greener, and Russell argue that the link 
between poverty and HIV/AIDS is weaker than that of income, gender equality, and HIV/AIDS. 
Fig. 3 shows the correlation between the GINI Coefficient and prevalence of HIV. The authors 
note that these factors affect social behaviors, including sexual behavior. Greener, along with 
Stuart Gillespie and Suneetha Kadiyala note that this is likely due to more frequent sexual 
partner changes among the wealthier and more educated. Because countries report a lower 
prevalence within poorer communities than wealthier ones, the authors state that “AIDS cannot 
Fig. 3 HIV Prevalence and Income Inequality in Africa. The Gini 
coefficient has a value between 0 and 1, representing the extremes of 
income distribution (Piot, Greener, and Russell). 
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accurately be termed a ‘disease of poverty’”. Nevertheless, they also write that poorer 
households suffer more due to the effects of the disease than richer households; in India financial 
burdens due to HIV/AIDS ranged from costing up to 82% of a family’s income for the poorest 
quintile and 20% for the richest (Piot, Greener, and Russell).  
 HIV/AIDS causes financial strain on families regardless of wealth status due to the high 
cost of treatment. Additionally, loss of work may occur due to infections or symptomatic 
episodes. However, studies regarding the relationship between HIV/AIDS and economic growth 
have shown contrasting results. In a Harvard Business School report by Amrita Ahuja, Brian 
Wendell, and Eric Werker, the association between the virus and economics was found to be 
“minimal” (38). The authors found that factors such as political stability and institutional 
development were more likely to aid in expansion. They note that the link between HIV/AIDS 
and SAC missing school was stronger than that of economic growth, though Jane G. Fortson of 
the University of Chicago writes that SAC affected by HIV/AIDS (either the child, a family 
member, or the teacher has the disease) will only lose 0.3 years of schooling compared to those 
not affected (13). SAC in especially endemic areas (10% prevalence or higher) may lose 0.5 
years of schooling. Alywn Young, a professor at the London School of Economics and Political 
Science argues that the epidemic has had a neutral effect on economic growth. He states that 
despite the negative association between HIV/AIDS and education, fertility declines due to the 
disease has mitigated over-population problems and therefore resulted in better, sustainable 
living conditions (Fortson 1). Reducing fertility rates offsets the negative effects regarding not 
only education, but adult work performance as well.  
HIV/AIDS in Ghana 
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 Ghana is ranked as the nation with the 34th highest prevalence of HIV/AIDS, preceded by 
fellow West African nation Guinea and followed by Mali and Sierra Leone (“Country 
Comparison: HIV/AIDS - Adult Prevalence Rate”). The disease affects approximately 1.47% of 
Ghanaians. According to the Ghana AIDS Commission, the GoG’s prevalence is highest in the 
Eastern, Ashanti, and Greater Accra Regions at 3.7%, 3.2%, and 2.7%, respectively (“Summary 
of the 2013…”). These regions are all located in the southern half of the country. Comparatively, 
in the rural north (where poverty rates are higher), regions tend to report a prevalence lower than 
average. Two of the three northernmost regions, the Northern and Upper West regions, document 
rates at about 0.8%. The government reports that the majority of new HIV/AIDS cases come 
from unprotected sexual intercourse between heterosexual couples in urban areas.  
 The Ghana AIDS Commission (GAC), the GoG’s national HIV/AIDS response, was 
created in 2002 in order to lessen the effects of the disease throughout the country. Since its 
implementation, UNAIDS estimates that the rate of HIV/AIDS among Ghanaians dropped from 
3.4% in 2002 to its current prevalence of 1.5% (“Country AIDS Response Progress 
Report – Ghana” 30). GAC’s success is most likely attributed to their education and policy 
campaigns. Awareness of the dangers of the virus and how to reduce the likelihood of 
contracting the disease has shown an increase in the use of condoms and increased knowledge of 
HIV/AIDS status (whether or not one is positive for the virus) (15). An individual knowing that 
they are positive for the virus results in the individual engaging in less unprotected sexual 
intercourse, whereas one that was unaware of their status would be less likely to increase their 
precautions without other cause. 
 Funding for HIV/AIDS in Ghana comes mainly from international organizations. In 
2011, $60,807,945 USD (or 74.4%) of support for the disease came from foreign funding (99). 
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Most of the money does not go directly to GAC, but rather NGOs, community-based 
organizations, or other public health programs (97). The GoG provided $14,854,634 USD 
(18.2%) and private sources such as domestic donations comprised the remaining 7.4%. Most 
international funding is allocated toward prevention or treatment, while the majority of public 
funding goes toward orphans that have lost their parents to HIV/AIDS or toward administration 
costs (the latter comprises 30.2% of the GoG’s support for HIV/AIDS). PEPFAR alone 
accounted for $15,000,000 USD in the same year (“Ghana Planned Funding, FY 2011”). 
 Ghana’s overall prevalence of HIV/AIDS, though distant from the high rates in Southern 
Africa, is similar to that of other West African nations such as Guinea, Mali, and Sierra Leone. 
These countries are notable as the countries that, along with Liberia, have suffered with an Ebola 
outbreak since the fall of 2014. Many scholars and scientists agree that the epidemic was 
widespread in these nations due to high poverty rates, inequality, and institutional strain 
following civil wars and political unrest. Without a stable healthcare system in place, the 
hemorrhagic fever was able to affect tens of thousands in West Africa. Though Ghana lacks 
comprehensive healthcare coverage, its political and economic stability are stronger than its 
neighbors and most other sub-Saharan African nations. However, despite the efforts of the GoG, 
GAC, and international organizations, prevalence remains high. 
Analysis & Discussion- Neglected Tropical Diseases vs. HIV/AIDS in Ghana: 
 The discrepancies between funding and disease prevalence are obvious. Though Ghana’s 
national funding for HIV/AIDS and NTDs is similar, global funding for the diseases is extremely 
disproportionate to the number of people they affect. NTDs affect over 14% of the world’s 
population, yet the largest international donor, the U.S., only dedicated 1.3% of their foreign 
health aid to the inflictions. HIV/AIDS affects about 1% of all people but receives 25% of all 
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international assistance for healthcare. Despite Ghana being ranked 34th highest for the 
prevalence of HIV/AIDS, foreign support for the disease in this nation alone accounts for as 
much funding as two-thirds of the US’s entire budget for NTD support. PEPFAR alone donated 
about $12,500,000 USD toward HIV/AIDS in 2013; the same amount was spent by the GoG on 
the NTD Programme the same year.  
 Allocating healthcare resources in low and low-middle income countries is not an easy 
task. To choose what conditions receive funding and what amount requires a thorough 
understanding of how the disease affects the population beyond just symptoms and 
communicability. Best approaches require knowledge of the social and economic impacts 
diseases have as well. Unfortunately, policy makers too often look at mortality rates while 
assessing the impacts of diseases. Even the DALY measurement for HIV/AIDS and NTDs offers 
a flawed perspective on disease consequence. HIV/AIDS has been responsible for an estimated 
81 million DALYs lost, and NTDs at 56.6 million. Though per person, HIV/AIDS appears to 
cause much more strain than NTDs, the ratio of YLL to YLD makes it difficult to compare the 
two. The majority of the DALY for HIV/AIDS comes from YLL while NTDs result in higher 
YLD. The DALY greatly underestimates the impact of YLD; for example, someone with a 
disability due to NTDs that lives a long life will likely need more care over their lifetime than 
someone living with HIV/AIDS (as their lifespan is typically shorter). Not only is the person 
inflicted with an NTD unable to attend school, work, or help with the home, but they will likely 
require a family member to care for them. This increases the financial strain a household may see 
due to disability or disfigurement, as the impact of the life of the care taker is not included into 
the DALY. 
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 Unfortunately it is impossible to fully understand the negative impact that NTDs have 
regarding economic development, especially in poor communities. Gathering data prevalence 
and transmission rates in low-resource areas is difficult on its own, and there is a scarcity of data 
regarding financial losses due to NTDs. However, the studies that have been done consistently 
report a correlation between control of NTDs and an increase in individual and community 
earning potential. Investments into prevention and control result in significant economic gains. 
The Hudson Institute cites studies which estimate that for every dollar that is spent on support for 
LF, a community will gain anywhere from $20 to $60 (Norris et. al 6). Providing surgery to 
prevent blindness due to trachoma was also cost-effective, yielding $13 to $78 per DALY 
averted (12). NTDs take a toll on communities by disabling their workers; for example, LF can 
cause the victim to lose up to 11 years of productivity, a number especially worsened by the fact 
that many of its victims work in the agricultural sector.  
 The average person may fall victim to the stereotype that HIV/AIDS is a disease of 
poverty and overestimate its effect on development. This is likely due to the awareness that the 
cause has received; charities and other organizations have painted a picture of an impoverished 
African continent ravaged by the condition. The global awareness for HIV/AIDS is widespread, 
and the cause receives so much in donations due to the work of charities such as (RED) and 
celebrities including Bono of the band U2. The UN is also responsible for showcasing the 
disease, as seen in its emphasis in MDG 6 and SDG 3. While any endemic disease with effects as 
harsh as those of HIV/AIDS will undoubtedly cause some economic loss, it is vital to remember 
that the virus is most common in the middle class. Though the poor see greater economic strain 
(due to the high cost of treatment and lack of available adequate care), for most households, an 
HIV/AIDS diagnosis is not a financial death sentence. On the other hand, the real diseases of 
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poverty, NTDs, perpetuate poor conditions and keep low-resource areas underdeveloped. Global 
awareness of the tropical conditions has remained low, despite the fact that the diseases have 
existed for centuries.  
 The UN should take a bigger role in highlighting the relationship between NTDs and 
poverty. The MDGs neglected to even mention NTDs, and the more recent SDGs seemed to 
mention the term in passing rather than note its importance. When discussing “facts and figures” 
related to the creation of SDG 3 (Good Health and Well-Being), HIV/AIDS and related terms 
was referenced over 10 times, while NTDs were again overshadowed as seen in the sub-heading 
“HIV/AIDS, Malaria, and other diseases” (“Goal 3: Ensure healthy…”). NTDs are mentioned 
only once during SDG 3’s target indicators, when the UN calls for the eradication of The Big 
Three, NTDs, hepatitis, water-borne diseases (which can include NTDs), and other 
communicable diseases. The link between NTDs, SDG 3, and SDGs 1 (No Poverty), 4 (Quality 
Education), 8 (Decent Work and Economic Growth), and 10 (Reduced Inequalities) is ignored. A 
larger emphasis on NTDs would add to the success of multiple goals and target some of the true 
causes of poverty. Meanwhile, HIV/AIDS is often viewed as a disease most commonly affecting 
the poor and thus receives more attention from the UN and other organizations. However, in 
many sub-Saharan African nations, this is not the case. While there is a strong correlation 
between inequality and the prevalence of the virus, it is often those in the middle class that are 
affected rather than those living in poverty. This is true in Ghana, where areas such as the 
Greater Accra region, an urban setting where the capital is located, has a prevalence over three 
times as high as the more rural Upper West region.  
 Ghana has seen success in combating HIV/AIDS transmission rates by decreasing the 
prevalence of the disease by more than half in just over a decade. While that is not to say that 
Brosch 27 
 
current efforts should cease (as they are obviously working), resources could be shifted to NTDs 
to reach more people and help develop the country’s economy, particularly in the northern 
regions. Ghana is regarded as one of the more developed nations in SSA, yet they rank among 
the highest for NTDs such as schistosomiasis, yaws, and Guinea worm. By eradicating or 
eliminating more diseases, the nation could see their poverty rates decrease and increased 
economic growth.  
 Misconceptions such as impact on poverty lead to disproportionate support for certain 
causes. Regarding international donations for healthcare, people are more likely to donate to 
causes they hear the most about. HIV/AIDS, the largest recipient of international health funding, 
while a terrible infliction, may not be the epidemic many think it is. For countries like Ghana 
where the condition is still considered of epidemic proportions (defined by the WHO as 1% or 
higher), support for HIV/AIDS may not be as beneficial as people think. Yes, funds are 
necessary to sustain a decline in transmission, but the abundance of funding may be better used 
in other areas. Given that the cost of treatment is hundreds to thousands of times higher for 
HIV/AIDS than NTDs, more people could be treated for their disabling conditions with even one 
million dollars more in support for the latter. A study by the Hudson Institute found that 
inexpensive MDA programs typically yield an economic return rate of 15% to 30% due to 
increased abilities to attend school and go to work. Impoverished communities could see rapid 
development through the use of comprehensive MDA to treat diseases such as schistosomiasis, 
lymphatic filariasis, and soil-transmitted helminthes. Scholars have debated on the true economic 
consequences of HIV/AIDS, but study after study has shown the positive effects that eliminating 
even just one NTD can have on a community.   
Conclusion: 
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 Countries and international organizations should allocate more assistance to citizens 
living in poverty in order to see better economic and social development. In the case of Ghana 
and NTDs, better healthcare coverage for the tropical conditions would result in more consistent 
education and higher productivity rates in endemic/impoverished areas, two important aspects of 
development. Social stigma, in addition to the physical disfigurements that NTDs cause, would 
diminish, and rural, underserved populations could break their cycle of poverty. Increased 
support for NTDs results in an increased economic development, especially for the poor. In 
contrast, increased support for HIV/AIDS, while successful, has shown neutral progress toward a 
country’s growth.  
 Countries like Ghana that have low rates of HIV/AIDS but a high prevalence of NTDs 
should also increase awareness of the latter conditions in order to encourage more international 
funding for the inflictions that are most prohibitive toward their development. Unfortunately 
support is too often given based on awareness of a cause rather than importance of that cause. 
International donors may think their funds are going to help the poor in Africa, although in some 
cases their donations may not reach the people they think they are helping. The UN should also 
offer better solutions for NTDs, rather than place them in the shadow of The Big Three. 
Knowledge of diseases beyond DALYs and mortality is necessary to understand which 
conditions affect which people and how so. For some sub-Saharan African countries, additional 
funding for the “other diseases” may be a huge component in aiding economic and social 
stability.  
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